IN-DATE
10-103: Inari FlowTriever 12F Embolectomy Catheter 15-18mm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $1,500.00 $525.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 43 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 14 hours 8 minutes and choose overnight shipping at checkout for Monday delivery. If you require Saturday delivery, please call to determine if it is available in your area - 888-416-2409. |
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in date item only.
Related Items
QUICK VIEW
| 10-102 - Size: 12.0F $525.00 per box of 1 Inari FlowTriever 12F Embolectomy Catheter 11-14mm Expired Units in stock: 39 box of 1 | Order Qty |
|
QUICK VIEW
| 10-104 - Size: 12.0F $525.00 per box of 1 Inari FlowTriever 12F Embolectomy Catheter 19-25mm Expired Units in stock: 42 box of 1 | Order Qty |
|
QUICK VIEW
| 10-101 - Size: 12.0F $525.00 per box of 1 Inari FlowTriever 12F Embolectomy Catheter 6-10mm Expired Units in stock: 41 box of 1 | Order Qty |
QUICK VIEW
| 11-102 - Size: 12.0F $1,249.50 per box of 1 Inari FlowTriever2 12F Embolectomy Catheter 6-16mm Expired Units in stock: 21 box of 1 | Order Qty |
Additional Details
Inari FlowTriever Embolectomy Catheter
10-103
- Size: 12F (4mm)
- Recommended Guidewire Size: 0.035" (0.9mm)
- Usable Length: 115cm
Manufacturer
Inari Medical specializes in innovative, catheter-based solutions for venous thromboembolism (VTE). Their flagship products include the ClotTriever system for mechanical thrombectomy in deep vein thrombosis (DVT) and the FlowTriever system, the first FDA-cleared device for pulmonary embolism (PE) treatment without the need for thrombolytics. These systems are designed to remove large clots in a single session, reducing the need for ICU stays, thrombolytic drugs, and prolonged hospitalizations. With a focus on transforming the treatment paradigm for venous disease, Inari is redefining outcomes for patients suffering from life-threatening clot-related conditions.
